Sage Therapeutics Cash from Financing (TTM) Trends

Sage Therapeutics Inc (SAGE)

14.00 +1.05 (+8.11%) USD | NASDAQ | Apr 24, 16:00

14.00 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	6.027M
September 30, 2023	6.318M
June 30, 2023	4.777M
March 31, 2023	3.943M
December 31, 2022	3.07M
September 30, 2022	2.871M
June 30, 2022	3.458M
March 31, 2022	9.51M
December 31, 2021	13.33M
September 30, 2021	433.18M
June 30, 2021	434.90M
March 31, 2021	429.22M
December 31, 2020	426.76M
September 30, 2020	9.257M
June 30, 2020	19.63M
March 31, 2020	34.59M
December 31, 2019	607.62M
September 30, 2019	607.09M
June 30, 2019	601.24M
March 31, 2019	592.44M
December 31, 2018	659.36M

Date	Value
September 30, 2018	992.55M
June 30, 2018	988.16M
March 31, 2018	984.38M
December 31, 2017	341.82M
September 30, 2017	7.676M
June 30, 2017	193.58M
March 31, 2017	190.83M
December 31, 2016	330.98M
September 30, 2016	330.34M
June 30, 2016	140.88M
March 31, 2016	270.46M
December 31, 2015	129.87M
September 30, 2015	129.59M
June 30, 2015	224.61M
March 31, 2015	94.00M
December 31, 2014	146.87M
September 30, 2014	147.38M
June 30, 2014	69.71M
March 31, 2014	70.76M
December 31, 2013	22.78M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.871M

Minimum

Sep 2022

607.62M

Maximum

Dec 2019

192.46M

Average

13.33M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks